Aptamers selected by cell-SELEX for application in cancer studies

Bioanalysis

Volumn 2, Issue 5, 2010, Pages 907-918

  Zhang, Yunfei ^a   Chen, Yan ^a   Han, Da ^a   Ocsoy, Ismail ^a   Tan, Weihong ^a  

^a University of Florida ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DOXORUBICIN; GOLD NANOPARTICLE; LIPOSOME; SILVER NANOPARTICLE; APTAMER; DRUG CARRIER;

CANCER CELL; CANCER RESEARCH; CANCER THERAPY; CELL SELECTION; CELL SPECIFICITY; COMBINATORIAL CHEMISTRY; CONJUGATION; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG STRUCTURE; DRUG TARGETING; ENRICHMENT CULTURE; HUMAN; MICELLE; MICROFLUIDIC ANALYSIS; MOLECULAR RECOGNITION; PROTEIN EXPRESSION; REVIEW; SENSITIVITY AND SPECIFICITY; TARGET CELL; ANIMAL; CELL SEPARATION; GENETICS; MEDICAL RESEARCH; METABOLISM; METHODOLOGY; NEOPLASM; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ANIMALS; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; BIOMEDICAL RESEARCH; CELL SEPARATION; DRUG CARRIERS; HUMANS; NEOPLASMS; SELEX APTAMER TECHNIQUE;

EID: 79952529043     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.46     Document Type: Review

References (51)

1. Kang WJ, Chae JR, Cho YL, Lee J, Kim S. Multiplex imaging of single tumor cells using quantum-dot-conjugated aptamers. Small 22, 2519-2522 (2009).
2. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 346(6287), 818-822 (1990). nn One of the first aptamer papers.
3. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510 (1990).
4. Osborne SE, Matsumura I, Ellington AD. Aptamers as therapeutic and diagnostic reagents: problems and prospects. Curr. Opin. Chem. Biol. 1, 5-9 (1997). (Pubitemid 127435139)
5. Famulok M, Hartig JS, Mayer G. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. Chem. Rev. 107, 3715-3743 (2007). (Pubitemid 47534316)
6. Navani NK, Li Y. Nucleic acid aptamers and enzymes as sensors. Curr. Opin. Chem. Biol. 10, 272-281 (2006). (Pubitemid 43815779)
7. Jiang Y, Zhu C, Ling L, Wan L, Fang X, Bai C. Specific aptamer-protein interaction studied by atomic force microscopy. Anal. Chem. 75, 2112-2116 (2003). (Pubitemid 36542352)
8. Ireson CR, Kelland LR. Discovery and development of anticancer aptamers. Mol. Cancer Ther. 5, 2957-2962 (2006). (Pubitemid 46092036)
9. Lupold SE, Hicke BJ, Liny Y, Coffey DS. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 62, 4029-4033 (2002). (Pubitemid 34791070)
10. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L. A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc. Natl Acad. Sci. USA 100, 15416-15421(2003). (Pubitemid 38021004)
11. Cerchia L, Ducongé F, Pestourie C et al. Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS. Biol. 3, E123 (2005).
12. Shamah SM, Healy JM, Cload ST. Complex target SELEX. Acc. Chem. Res. 41, 130-138 (2008).
13. Blank M, Weinschenk T, Priemer M, Schluesener H. Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. Selective targeting of endothelial regulatory protein pigpen. J. Biol. Chem. 276, 16464-16468 (2001).
14. Berezovski MV, Lechmann M, Musheev MU, Mak TW, Krylov SN. Aptamer-facilitated biomarker discovery (AptaBiD).J. Am. Chem. Soc. 130, 9137-9143 (2008).
15. Guo K, Schafer R, Paul A, Gerber A, Ziemer G, Wendel HP. A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells 24, 2220-2231 (2006). (Pubitemid 44527475)
16. Raddatz ML, Dolf A, Endl E, Knolle P, Famulok M, Mayer G. Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell orting. Angew. Chem. Int. Ed. 47, 5190-5193 (2008).
17. Shangguan D, Li Y, Tang Z, Cao Z et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc. Natl Acad. Sci. USA 103, 11838-11843 (2006). (Pubitemid 44215773)
18. Sefah K, Tang Z, Shangguan D et al. Molecular recognition of acute myeloid leukemia using aptamers. Leukemia 23, 235-244 (2009).
19. Chen H, Medley C, Sefah K et al. Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem. 3, 991-1001 (2008).
20. Tang Z, Shangguan D, Wang K et al. Selection of aptamers for molecular recognition and characterization of cancer cells. Anal. Chem. 79, 4900-4907 (2007). (Pubitemid 47051443)
21. Zhao Z, Xu L, Shi X, Tan W, Fang X, Shangguan D. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells Analyst 134, 1808-1814 (2009).
22. Smith J, Medley C, Tang Z, Shangguan D, Lofton C, Tan W. Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. Anal. Chem. 79, 3075-3082 (2007). (Pubitemid 46640529)
23. Medley C, Smith J, Tang Z ,Wu Y, Bamrungsap S, Tan W. Gold nanoparticlebased colorimetric assay for the direct detection of cancerous cells. Anal. Chem. 80, 1067-1072 (2008). (Pubitemid 351272339)
24. Zhang J, Jia X, Lv X, Deng Y, Xie H. Fluorescent quantum dot-labeled aptamer bioprobes specifically targeting mouse liver cancer cells. Talanta 81(1-2), 505-509 (2010).
25. Chu TC, Shieh F, Lavery LA et al. Labeling tumor cells with fluorescent nanocrystal- aptamer bioconjugates, Biosens. Bioelectron. 21, 1859-1866 (2006).
26. Huang Y, Chang H, Tan W. Cancer cell targeting using multiple aptamers conjugated on nanorods. Anal. Chem. 80, 567-572 (2008). (Pubitemid 351206842)
27. Herr J, Smith J, Medley C, Shangguan D, Tan W. Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Anal. Chem. 78, 2918-2924 (2006). (Pubitemid 43726108)
28. Phillips J, Xu Y, Xia Z, Fan Z, Tan W. Enrichment of cancer cells using aptamers immobilized on a microfluidic channel. Anal. Chem. 81, 1033-1039 (2009).
29. Liotta L, Saidel M, Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res. 36, 889-894 (1976).
30. Nagrath S, Sequist L, Maheswaran S et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235-1239 (2007).
31. Dharmasiri U, Balamurugan S, Adams A, Okagbare P, Obubuafo A, Soper S. Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate-specific membrane antigen aptamers immobilized to a polymeric microfluidic device. Electrophoresis 30, 3289-3300 (2009).
32. Xu Y, Philips JA, Yan J, Li Q, Fan ZH, Tan W. Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. Anal. Chem. 81(17), 7436-7442(2009).
33. Gu W, Zhu X, Futai N, Cho BS, Takayama S. Computerized microfluidic cell culture using elastomeric channels and braille displays. Proc. Natl Acad. Sci. USA 101, 15861-15866 (2004). (Pubitemid 39507892)
34. Marcus JS, Anderson WF, Quake SR. Microfluidic single-cell mRNA isolation and analysis. Anal. Chem. 78, 3084-3089 (2006). (Pubitemid 43726129)
35. Trail PA, Willner D, Lasch SJ et al. Cure of xenografted human carcinomas by BR96- doxorubicin immunoconjugates. Science 261, 212-215 (1993). (Pubitemid 23265398)
36. Laurent D, Bernhard S. Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies. Bioconjugate Chem. 21, 5-13 (2010).
37. Kirpotin DB, Drummond DC, Shao Y et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 66, 6732 (2006).
38. Sapra P, Allen TM. Ligand-targeted liposomal anticancer drugs. Prog. Lipid Res. 42, 439 (2003).
39. Bagalkot V, Zhang L, Levy-Nissenbaum E et al. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bifluorescence resonance energy transfer. Nano Lett. 7, 3065 (2007).
40. Huang Y, Shangguan D, Liu H et al. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. ChemBioChem. 10, 862 (2009).
41. Shangguan D, Cao Z, Meng L et al. Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J. Proteome Res. 7, 2133-2139 (2008).
42. Weiss RB, Sarosy G, Clagett-Carr K, Russo M, Leyland-Jones B. Anthracycline analogs: the past, present, and future. Cancer Chemother. Pharmacol. 18, 185-197 (1986). (Pubitemid 17007730)
43. Cao Z, Tong R, Mishra A et al. Reversible cell-specific drug delivery with aptamerfunctionalized liposomes. Angew. Chem. Int. Ed. 48, 6494-6498 (2009).
44. Wu Y, Sefah K, Liu H, Wang R, Tan W. DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells. PNAS 107(1), 5-10 (2010).
45. Willis MC, Collins B, Zhang T et al. Liposome-anchored vascular endothelial growth factor aptamers. Bioconjugate Chem. 9, 573 (1998).
46. Kang H, O'Donoghue MB, Liu H, Tan W. A liposome-based nanostructure for aptamer directed delivery Chem. Commun. 46, 249-251 (2010).
47. Seddon JM, Templer RH. Reversible Cell-Specific Drug Delivery with Aptamer- Functionalized Liposomes (Volume 1).Elsevier Science, Oxford, UK (1995).
48. Ding K, Alemdaroglu FE, Borsch M, Berger R, Herrmann A. Engineering the structural properties of DNA block copolymer micelles by molecular recognition. Angew. Chem. Int. Ed. Engl. 46, 1172-1175 (2007). (Pubitemid 46959377)
49. Alemdaroglu FE, Alemdaroglu NC, Langguth P, Herrmann A. Cellular uptake of DNA block copolymer micelles with different shapes. Macromol. Rapid Commun. 29, 326-329 (2008).
50. Jeong JH, Park TG. Novel polymer-DNA hybrid polymeric micelles composed of hydrophobic poly (d,l-lactic-co-glycolic acid) and hydrophilic oligonucleotides. Bioconjugate Chem. 12, 917-923 (2001). (Pubitemid 33136861)
51. Chen H, Kim S, Li L, Wang S, Park K, Cheng J. Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging. Proc. Natl Acad. Sci. USA 105, 6596-6601 (2008). (Pubitemid 351754552)